|
|
Vol. 15.08 – 07 May, 2026
|
|
|
|
|
|
|
|
|
Researchers developed an efficacious compound K (CK) derivative, CKD-4 with significantly enhanced cancer cell penetration and cytotoxicity both in vitro and in vivo. [Proceedings of the National Academy of Sciences of the United States of America]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
Scientists demonstrated that plasma growth differentiation factor 15 (GDF15) is elevated across diverse fibrotic lung disease subtypes and correlates with markers of elevated right heart pressures, but not pulmonary function indices, indicating a possible link to endothelial cell dysfunction.
[JCI Insight]
|
|
|
|
|
|
Researchers identified alanine as an essential metabolite for myofibroblast differentiation. Transforming growth factor–β1 (TGF-β) increases intracellular alanine levels through enhanced synthesis and import in both normal and idiopathic pulmonary fibrosis lung fibroblasts.
[JCI Insight]
|
|
|
|
|
|
The authors reported the discovery of NP12, the first SAMHD1 degrader with intracellular activity. In a bleomycin-induced pulmonary fibrosis mouse model, NP12 delayed pulmonary fibrosis progression and exerted a protective effect on lung tissue.
[Journal of Medicinal Chemistry]
|
|
|
|
|
|
Investigators demonstrated that the FAM13A long isoform is critical to patterning NKX2-1 + lung progenitor cells through dysregulating Wnt/β-catenin signaling during early stages of development in vitro.
[American Journal of Respiratory Cell and Molecular Biology]
|
|
|
|
|
|
Scientists investigated the induction of the epithelial-mesenchymal transition of human bronchial epithelial cells BEAS-2B following six weeks of treatment with multi-walled carbon nanotubes ranging from 0.125 to 1 µg/cm2.
[Archives of Toxicology]
|
|
|
|
|
|
|
|
Researchers investigated whether lactate dehydrogenase C4 (LDHC4) promotes lung adenocarcinoma by modulating protein lactylation, a lactate-derived post-translational modification, focusing on the tumor suppressor retinoblastoma protein (RB1). [Journal of Translational Medicine]
|
|
|
|
|
|
|
|
The authors examines challenges, compare SIRT1’s divergent roles, and evaluate chronotherapy, biomarker-guided selection, and SIRT1 activators. [iScience]
|
|
|
|
|
|
|
|
Nuvation Bio, Inc. announced today that the US FDA has accepted a supplemental New Drug Application with updated data for IBTROZI® (taletrectinib) in both TKI-naïve and TKI-pretreated advanced ROS1-positive NSCLC. [Nuvation Bio, Inc.]
|
|
|
|
|
|
|
|
June 8-11, 2026 Budapest, Hungary
|
|
|
|
|
|
|
|
|
|
|
Medical University of Vienna – Vienna, Austria
|
|
|
|
|
|
|
The Icahn School of Medicine at Mount Sinai – New York City, New York, United States
|
|
|
|
|
|
|
The University of Texas MD Anderson Cancer Center – Houston, Texas, United States
|
|
|
|
|
|
|
Indiana University – Indianapolis, Indiana, United States
|
|
|
|
|
|
|
Heidelberg University – Heidelberg, Germany
|
|
|
|
|
|